tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Aquestive Therapeutics (AQST)
NASDAQ:AQST
US Market
AQST
Aquestive Therapeutics
RESEARCH TOOLSreports

Aquestive Therapeutics (AQST) Stock News & Sentiment

Compare
2,443 Followers
Reaffirming Buy on Anaphylm: Navigable FDA CRL, Limited Incremental Costs, and Intact 2027 Approval Timeline
Premium
Ratings
Reaffirming Buy on Anaphylm: Navigable FDA CRL, Limited Incremental Costs, and Intact 2027 Approval Timeline
3d ago
AQST
Buy Rating Reaffirmed on Aquestive Therapeutics as Operational FDA Setbacks De-Risk Anaphylm’s Path to Approval
Premium
Ratings
Buy Rating Reaffirmed on Aquestive Therapeutics as Operational FDA Setbacks De-Risk Anaphylm’s Path to Approval
4d ago
AQST
Buy Rating Maintained on Aquestive Therapeutics as FDA CRL Seen as Operational Setback with Manageable Risk and Attractive Long‑Term Risk‑Reward
Premium
Ratings
Buy Rating Maintained on Aquestive Therapeutics as FDA CRL Seen as Operational Setback with Manageable Risk and Attractive Long‑Term Risk‑Reward
4d ago
AQST
FDA Issues Complete Response Letter on Anaphylm Application
Premium
Company Announcements
FDA Issues Complete Response Letter on Anaphylm Application
4d ago
8K
AQST
FDA Calendar: These Are the Remaining Drug Approvals Anticipated This Month
Premium
Market News
FDA Calendar: These Are the Remaining Drug Approvals Anticipated This Month
8d ago
AQST
IRON
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
27d ago
BE
GM
Why Is Aquestive Therapeutics Stock (AQST) Down Today?
Premium
Market News
Why Is Aquestive Therapeutics Stock (AQST) Down Today?
28d ago
AQST
More AQST News >

AQST News on the Web

Aquestive Therapeutics (AQST) Stock Surges 39% Despite FDA Setback
GuruFocus News
Bearish
FDA Response Prompts Aquestive Therapeutics (AQST) to Expedite Anaphylm Resubmission
GuruFocus News
Bullish
Aquestive Therapeutics (AQST) Faces Setback with FDA Letter but Path to Approval Remains
GuruFocus News
Bearish
FDA Communication Boosts Confidence in Aquestive Therapeutics (AQST)
GuruFocus News
Bullish
AQST’s FDA Roadblock Is Packaging, Not Product—Anaphylm’s Path Forward Looks Manageable
Market Chameleon
Neutral
FDA Raises Packaging Concerns for Aquestive’s Anaphylm, but Company Eyes Rapid Resolution and Global Expansion
Market Chameleon
Neutral
FDA Calendar: These Are the Remaining Drug Approvals Anticipated This Month
TipRanks News
Bullish
Here's Why Aquestive Therapeutics (AQST) Is a Great 'Buy the Bottom' Stock Now
Zacks
Bullish

News Score - Last 7 Days

Neutral
AQST
Sector Average
Media Buzz
This Week6 articles
Weekly Average2.75 articles
News Sentiment
This Week50%
Sector Average74%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AQST’s Media Buzz Sentiment?
6 articles about AQST were published this week. In an average week, 2.75 articles are published.
    What is AQST’s weekly average amount of articles?
    In an average week, 2.75 articles about AQST are published.
      What is AQST’s News Sentiment?
      50% of articles about AQST were positive this week, compared to its sector average of 74%.
        Healthcare Stocks that are Trending in the News
        TECHBio-Techne
        MMSIMerit Medical Systems
        DVADaVita
        ALGNAlign Tech
        STARStrides Pharma Science Ltd
        Showing the stocks with the most bullish news sentiment over the past week